|
|
Previous Article | Table of Contents | Next Article 
Blood, Vol. 96 No. 3 (August 1), 2000:
pp. 878-884
In vivo generation of human dendritic cell subsets by Flt3 ligand
Eugene Maraskovsky,
Elizabeth Daro,
Eileen Roux,
Mark Teepe,
Charlie R. Maliszewski,
Jeannie Hoek,
Dania Caron,
Mel E. Lebsack, and
Hilary J. McKenna
From Immunex Corporation, Seattle, WA.
Dendritic cells (DCs) represent a family of ontogenically distinct
leukocytes involved in immune response regulation. The ability of DCs
to stimulate T-cell immunity has led to their use as vectors for
immunotherapy vaccines. However, it is unclear whether and to what
degree in vitro-generated DCs are representative of DCs that develop
in vivo. Treatment of mice with human Flt3 ligand (FL) dramatically
increases the number of DCs. We report here that administration of FL
to healthy human volunteers increased the number of circulating
CD11c+ IL-3R low DC (mean 44-fold) and
CD11c IL-3R high DC precursors (mean
12-fold). Moreover, the CD11c+ DCs were efficient
stimulators of T cells in vitro. Thus, FL can expand the number of
circulating, functionally competent human DCs in vivo.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
P. J. Dunne, B. Moran, R. C. Cummins, and K. H. G. Mills
CD11c+CD8{alpha}+ Dendritic Cells Promote Protective Immunity to Respiratory Infection with Bordetella pertussis
J. Immunol.,
July 1, 2009;
183(1):
400 - 410.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. R. Mott, D. UnderHill, S. L. Wechsler, and H. Ghiasi
Lymphoid-Related CD11c+ CD8{alpha}+ Dendritic Cells Are Involved in Enhancing Herpes Simplex Virus Type 1 Latency
J. Virol.,
October 15, 2008;
82(20):
9870 - 9879.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Kenins, J. W. Gill, R. L. Boyd, G. A. Hollander, and A. Wodnar-Filipowicz
Intrathymic expression of Flt3 ligand enhances thymic recovery after irradiation
J. Exp. Med.,
March 17, 2008;
205(3):
523 - 531.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. L. Papenfuss, A. P. Kithcart, N. D. Powell, M. A. McClain, I. E. Gienapp, T. M. Shawler, and C. C. Whitacre
Disease-modifying capability of murine Flt3-ligand DCs in experimental autoimmune encephalomyelitis
J. Leukoc. Biol.,
December 1, 2007;
82(6):
1510 - 1518.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Triccas, E. Shklovskaya, J. Spratt, A. A. Ryan, U. Palendira, B. Fazekas de StGroth, and W. J. Britton
Effects of DNA- and Mycobacterium bovis BCG-Based Delivery of the Flt3 Ligand on Protective Immunity to Mycobacterium tuberculosis
Infect. Immun.,
November 1, 2007;
75(11):
5368 - 5375.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Kwissa, R. R. Amara, H. L. Robinson, B. Moss, S. Alkan, A. Jabbar, F. Villinger, and B. Pulendran
Adjuvanting a DNA vaccine with a TLR9 ligand plus Flt3 ligand results in enhanced cellular immunity against the simian immunodeficiency virus
J. Exp. Med.,
October 29, 2007;
204(11):
2733 - 2746.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Orlandi, F. M. Venanzi, A. Concetti, H. Yamauchi, S. Tiwari, L. Norton, J. D. Wolchok, A. N. Houghton, and P. D. Gregor
Antibody and CD8+ T Cell Responses against HER2/neu Required for Tumor Eradication after DNA Immunization with a Flt-3 Ligand Fusion Vaccine
Clin. Cancer Res.,
October 15, 2007;
13(20):
6195 - 6203.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Piccioli, S. Tavarini, E. Borgogni, V. Steri, S. Nuti, C. Sammicheli, M. Bardelli, D. Montagna, F. Locatelli, and A. Wack
Functional specialization of human circulating CD16 and CD1c myeloid dendritic-cell subsets
Blood,
June 15, 2007;
109(12):
5371 - 5379.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. H. Lim, S. Kireta, G. R. Russ, and P. T. H. Coates
Human plasmacytoid dendritic cells regulate immune responses to Epstein-Barr virus (EBV) infection and delay EBV-related mortality in humanized NOD-SCID mice
Blood,
February 1, 2007;
109(3):
1043 - 1050.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. S. Kim, S. H. Yang, H. G. Kang, E. Y. Seong, S. H. Lee, W. Gao, J. Kenny, X. X. Zheng, and T. B. Strom
Distinctive role of donor strain immature dendritic cells in the creation of allograft tolerance
Int. Immunol.,
December 1, 2006;
18(12):
1771 - 1777.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Olivier, E. Lauret, P. Gonin, and A. Galy
The Notch ligand delta-1 is a hematopoietic development cofactor for plasmacytoid dendritic cells
Blood,
April 1, 2006;
107(7):
2694 - 2701.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Tussiwand, N. Onai, L. Mazzucchelli, and M. G. Manz
Inhibition of Natural Type I IFN-Producing and Dendritic Cell Development by a Small Molecule Receptor Tyrosine Kinase Inhibitor with Flt3 Affinity
J. Immunol.,
September 15, 2005;
175(6):
3674 - 3680.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Vermaelen and R. Pauwels
Pulmonary Dendritic Cells
Am. J. Respir. Crit. Care Med.,
September 1, 2005;
172(5):
530 - 551.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Rossi and J. W. Young
Human Dendritic Cells: Potent Antigen-Presenting Cells at the Crossroads of Innate and Adaptive Immunity
J. Immunol.,
August 1, 2005;
175(3):
1373 - 1381.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Dalgaard, K. J. Beckstrom, F. L. Jahnsen, and J. E. Brinchmann
Differential capability for phagocytosis of apoptotic and necrotic leukemia cells by human peripheral blood dendritic cell subsets
J. Leukoc. Biol.,
May 1, 2005;
77(5):
689 - 698.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. O'Keeffe, T. C. Brodnicki, B. Fancke, D. Vremec, G. Morahan, E. Maraskovsky, R. Steptoe, L. C. Harrison, and K. Shortman
Fms-like tyrosine kinase 3 ligand administration overcomes a genetically determined dendritic cell deficiency in NOD mice and protects against diabetes development
Int. Immunol.,
March 1, 2005;
17(3):
307 - 314.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Rolland, L. Guyon, M. Gill, Y.-H. Cai, J. Banchereau, K. McClain, and A. K. Palucka
Increased Blood Myeloid Dendritic Cells and Dendritic Cell-Poietins in Langerhans Cell Histiocytosis
J. Immunol.,
March 1, 2005;
174(5):
3067 - 3071.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. McKenna, A.-S. Beignon, and N. Bhardwaj
Plasmacytoid Dendritic Cells: Linking Innate and Adaptive Immunity
J. Virol.,
January 1, 2005;
79(1):
17 - 27.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. E. Toliver-Kinsky, W. Cui, E. D. Murphey, C. Lin, and E. R. Sherwood
Enhancement of Dendritic Cell Production by Fms-Like Tyrosine Kinase-3 Ligand Increases the Resistance of Mice to a Burn Wound Infection
J. Immunol.,
January 1, 2005;
174(1):
404 - 410.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Beckebaum, X. Zhang, X. Chen, Z. Yu, A. Frilling, G. Dworacki, H. Grosse-Wilde, C. E. Broelsch, G. Gerken, and V. R. Cicinnati
Increased Levels of Interleukin-10 in Serum from Patients with Hepatocellular Carcinoma Correlate with Profound Numerical Deficiencies and Immature Phenotype of Circulating Dendritic Cell Subsets
Clin. Cancer Res.,
November 1, 2004;
10(21):
7260 - 7269.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. F. Fagnoni, B. Oliviero, G. Giorgiani, P. De Stefano, A. Deho, C. Zibera, N. Gibelli, R. Maccario, G. Da Prada, M. Zecca, et al.
Reconstitution dynamics of plasmacytoid and myeloid dendritic cell precursors after allogeneic myeloablative hematopoietic stem cell transplantation
Blood,
July 1, 2004;
104(1):
281 - 289.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Teleshova, J. Jones, J. Kenney, J. Purcell, R. Bohm, A. Gettie, and M. Pope
Short-term Flt3L treatment effectively mobilizes functional macaque dendritic cells
J. Leukoc. Biol.,
June 1, 2004;
75(6):
1102 - 1110.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Wang, A. Castellaneta, A. De Creus, W. J. Shufesky, A. E. Morelli, and A. W. Thomson
Heart, but Not Skin, Allografts from Donors Lacking Flt3 Ligand Exhibit Markedly Prolonged Survival Time
J. Immunol.,
May 15, 2004;
172(10):
5924 - 5930.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Chklovskaia, P. Nowbakht, C. Nissen, A. Gratwohl, M. Bargetzi, and A. Wodnar-Filipowicz
Reconstitution of dendritic and natural killer-cell subsets after allogeneic stem cell transplantation: effects of endogenous flt3 ligand
Blood,
May 15, 2004;
103(10):
3860 - 3868.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Chen, S. Antonenko, J. M. Sederstrom, X. Liang, A. S. H. Chan, H. Kanzler, B. Blom, B. R. Blazar, and Y.-J. Liu
Thrombopoietin cooperates with FLT3-ligand in the generation of plasmacytoid dendritic cell precursors from human hematopoietic progenitors
Blood,
April 1, 2004;
103(7):
2547 - 2553.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Taieb, K. Maruyama, C. Borg, M. Terme, L. Zitvogel, S. Appel, and P. Brossart
Imatinib mesylate impairs Flt3L-mediated dendritic cell expansion and antitumor effects in vivo
Blood,
March 1, 2004;
103(5):
1966 - 1967.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. S. Higano, N. J. Vogelzang, J. A. Sosman, A. Feng, D. Caron, and E. J Small
Safety and Biological Activity of Repeated Doses of Recombinant Human Flt3 Ligand in Patients with Bone Scan-Negative Hormone-Refractory Prostate Cancer
Clin. Cancer Res.,
February 15, 2004;
10(4):
1219 - 1225.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Wodnar-Filipowicz
Flt3 Ligand: Role in Control of Hematopoietic and Immune Functions of the Bone Marrow
Physiology,
December 1, 2003;
18(6):
247 - 251.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. S. Freedman, S. Vadhan-Raj, C. Butts, C. Savary, B. Melichar, C. Verschraegen, J. J. Kavanagh, M. E. Hicks, L. B. Levy, J. K. Folloder, et al.
Pilot Study of Flt3 Ligand Comparing Intraperitoneal with Subcutaneous Routes on Hematologic and Immunologic Responses in Patients with Peritoneal Carcinomatosis and Mesotheliomas
Clin. Cancer Res.,
November 1, 2003;
9(14):
5228 - 5237.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. T. H. Coates, S. M. Barratt-Boyes, L. Zhang, V. S. Donnenberg, P. J. O'Connell, A. J. Logar, F. J. Duncan, M. Murphey-Corb, A. D. Donnenberg, A. E. Morelli, et al.
Dendritic cell subsets in blood and lymphoid tissue of rhesus monkeys and their mobilization with Flt3 ligand
Blood,
October 1, 2003;
102(7):
2513 - 2521.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Jefford, M. Schnurr, T. Toy, K.-A. Masterman, A. Shin, T. Beecroft, T. Y. Tai, K. Shortman, M. Shackleton, I. D. Davis, et al.
Functional comparison of DCs generated in vivo with Flt3 ligand or in vitro from blood monocytes: differential regulation of function by specific classes of physiologic stimuli
Blood,
September 1, 2003;
102(5):
1753 - 1763.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. D'Amico and L. Wu
The Early Progenitors of Mouse Dendritic Cells and Plasmacytoid Predendritic Cells Are within the Bone Marrow Hemopoietic Precursors Expressing Flt3
J. Exp. Med.,
July 21, 2003;
198(2):
293 - 303.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. E. Toliver-Kinsky, C. Y. Lin, D. N. Herndon, and E. R. Sherwood
Stimulation of Hematopoiesis by the Fms-Like Tyrosine Kinase 3 Ligand Restores Bacterial Induction of Th1 Cytokines in Thermally Injured Mice
Infect. Immun.,
June 1, 2003;
71(6):
3058 - 3067.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. J. Manfra, S.-C. Chen, K. K. Jensen, J. S. Fine, M. T. Wiekowski, and S. A. Lira
Conditional Expression of Murine Flt3 Ligand Leads to Expansion of Multiple Dendritic Cell Subsets in Peripheral Blood and Tissues of Transgenic Mice
J. Immunol.,
March 15, 2003;
170(6):
2843 - 2852.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Vuckovic, M. Kim, D. Khalil, C. J. Turtle, G. V. Crosbie, N. Williams, L. Brown, K. Williams, C. Kelly, P. Stravos, et al.
Granulocyte-colony stimulating factor increases CD123hi blood dendritic cells with altered CD62L and CCR7 expression
Blood,
March 15, 2003;
101(6):
2314 - 2317.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Sailaja, S. Husain, B. P. Nayak, and A. M. Jabbar
Long-Term Maintenance of gp120-Specific Immune Responses by Genetic Vaccination with the HIV-1 Envelope Genes Linked to the Gene Encoding Flt-3 Ligand
J. Immunol.,
March 1, 2003;
170(5):
2496 - 2507.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. O'Keeffe, H. Hochrein, D. Vremec, B. Scott, P. Hertzog, L. Tatarczuch, and K. Shortman
Dendritic cell precursor populations of mouse blood: identification of the murine homologues of human blood plasmacytoid pre-DC2 and CD11c+ DC1 precursors
Blood,
February 15, 2003;
101(4):
1453 - 1459.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. D. Davis, M. Jefford, P. Parente, and J. Cebon
Rational approaches to human cancer immunotherapy
J. Leukoc. Biol.,
January 1, 2003;
73(1):
3 - 29.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Brawand, D. R. Fitzpatrick, B. W. Greenfield, K. Brasel, C. R. Maliszewski, and T. De Smedt
Murine Plasmacytoid Pre-Dendritic Cells Generated from Flt3 Ligand-Supplemented Bone Marrow Cultures Are Immature APCs
J. Immunol.,
December 15, 2002;
169(12):
6711 - 6719.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Mwangi, W. C. Brown, H. A. Lewin, C. J. Howard, J. C. Hope, T. V. Baszler, P. Caplazi, J. Abbott, and G. H. Palmer
DNA-Encoded Fetal Liver Tyrosine Kinase 3 Ligand and Granulocyte Macrophage-Colony-Stimulating Factor Increase Dendritic Cell Recruitment to the Inoculation Site and Enhance Antigen-Specific CD4+ T Cell Responses Induced by DNA Vaccination of Outbred Animals
J. Immunol.,
October 1, 2002;
169(7):
3837 - 3846.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. J Mosca, A. C. Hobeika, K. Colling, T. M. Clay, E. K. Thomas, D. Caron, H. K. Lyerly, and M. A. Morse
Multiple signals are required for maturation of human dendritic cells mobilized in vivo with Flt3 ligand
J. Leukoc. Biol.,
September 1, 2002;
72(3):
546 - 553.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. G. Gilliland and J. D. Griffin
The roles of FLT3 in hematopoiesis and leukemia
Blood,
August 13, 2002;
100(5):
1532 - 1542.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Luft, M. Jefford, P. Luetjens, T. Toy, H. Hochrein, K.-A. Masterman, C. Maliszewski, K. Shortman, J. Cebon, and E. Maraskovsky
Functionally distinct dendritic cell (DC) populations induced by physiologic stimuli: prostaglandin E2 regulates the migratory capacity of specific DC subsets
Blood,
July 30, 2002;
100(4):
1362 - 1372.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. R. Comeau, A.-R. Van der Vuurst de Vries, C. R. Maliszewski, and L. Galibert
CD123bright Plasmacytoid Predendritic Cells: Progenitors Undergoing Cell Fate Conversion?
J. Immunol.,
July 1, 2002;
169(1):
75 - 83.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. J. Steptoe, J. M. Ritchie, and L. C. Harrison
Increased Generation of Dendritic Cells from Myeloid Progenitors in Autoimmune-Prone Nonobese Diabetic Mice
J. Immunol.,
May 15, 2002;
168(10):
5032 - 5041.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. L. Disis, K. Rinn, K. L. Knutson, D. Davis, D. Caron, C. dela Rosa, and K. Schiffman
Flt3 ligand as a vaccine adjuvant in association with HER-2/neu peptide-based vaccines in patients with HER-2/neu-overexpressing cancers
Blood,
April 15, 2002;
99(8):
2845 - 2850.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. O'Keeffe, H. Hochrein, D. Vremec, J. Pooley, R. Evans, S. Woulfe, and K. Shortman
Effects of administration of progenipoietin 1, Flt-3 ligand, granulocyte colony-stimulating factor, and pegylated granulocyte-macrophage colony-stimulating factor on dendritic cell subsets in mice
Blood,
March 15, 2002;
99(6):
2122 - 2130.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. Timmerman, D. K. Czerwinski, T. A. Davis, F. J. Hsu, C. Benike, Z. M. Hao, B. Taidi, R. Rajapaksa, C. B. Caspar, C. Y. Okada, et al.
Idiotype-pulsed dendritic cell vaccination for B-cell lymphoma: clinical and immune responses in 35 patients
Blood,
March 1, 2002;
99(5):
1517 - 1526.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Luft, M. Jefford, P. Luetjens, H. Hochrein, K.-A. Masterman, C. Maliszewski, K. Shortman, J. Cebon, and E. Maraskovsky
IL-1{beta} Enhances CD40 Ligand-Mediated Cytokine Secretion by Human Dendritic Cells (DC): A Mechanism for T Cell-Independent DC Activation
J. Immunol.,
January 15, 2002;
168(2):
713 - 722.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. F. Lipscomb and B. J. Masten
Dendritic Cells: Immune Regulators in Health and Disease
Physiol Rev,
January 1, 2002;
82(1):
97 - 130.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. J. O'Connell, W. Li, Z. Wang, S. M. Specht, A. J. Logar, and A. W. Thomson
Immature and Mature CD8{alpha}+ Dendritic Cells Prolong the Survival of Vascularized Heart Allografts
J. Immunol.,
January 1, 2002;
168(1):
143 - 154.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Donaghy, A. Pozniak, B. Gazzard, N. Qazi, J. Gilmour, F. Gotch, and S. Patterson
Loss of blood CD11c+ myeloid and CD11c{-} plasmacytoid dendritic cells in patients with HIV-1 infection correlates with HIV-1 RNA virus load
Blood,
October 15, 2001;
98(8):
2574 - 2576.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Soumelis, I. Scott, F. Gheyas, D. Bouhour, G. Cozon, L. Cotte, L. Huang, J. A. Levy, and Y.-J. Liu
Depletion of circulating natural type 1 interferon-producing cells in HIV-infected AIDS patients
Blood,
August 15, 2001;
98(4):
906 - 912.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. R. Riddell
Progress in cancer vaccines by enhanced self-presentation
PNAS,
July 31, 2001;
98(16):
8933 - 8935.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Curti, M. Fogli, M. Ratta, S. Tura, and R. M. Lemoli
Stem Cell Factor and FLT3-Ligand Are Strictly Required to Sustain the Long-Term Expansion of Primitive CD34+DR- Dendritic Cell Precursors
J. Immunol.,
January 15, 2001;
166(2):
848 - 854.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Banchereau, B. Pulendran, R. Steinman, and K. Palucka
Will the Making of Plasmacytoid Dendritic Cells in Vitro Help Unravel Their Mysteries?
J. Exp. Med.,
December 18, 2000;
192(12):
f39 - f44.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Baggers, G. Ratzinger, and J. W. Young
Dendritic Cells as Immunologic Adjuvants for the Treatment of Cancer
J. Clin. Oncol.,
December 1, 2000;
18(23):
3879 - 3882.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Fong, Y. Hou, A. Rivas, C. Benike, A. Yuen, G. A. Fisher, M. M. Davis, and E. G. Engleman
Altered peptide ligand vaccination with Flt3 ligand expanded dendritic cells for tumor immunotherapy
PNAS,
July 17, 2001;
98(15):
8809 - 8814.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|